Cost-minimization analysis of genetic testing versus clinical screening of at-risk relatives for familial adenomatous polyposis

International Journal of Technology Assessment in Health Care

Volumn 18, Issue 1, 2002, Pages 67-80

  Chikhaoui, Yamina ^a   Gélinas, Huguette ^a   Joseph, Lawrence ^b   Lance, Jean Marie ^a  

^a Quebec Agency for Health Services and Technology Assessment   (Canada)

^b MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

At risk relatives; Clinical screening; Cost analysis; Familial adenomatous polyposis; Genetic testing

Indexed keywords

ADENOMATOUS POLYP; ARTICLE; CANCER RISK; CLINICAL EXAMINATION; COLORECTAL CANCER; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DECISION MAKING; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; GENETIC SCREENING; HEALTH CARE COST; HEALTH CARE SYSTEM; HUMAN; INTERMETHOD COMPARISON; PREDICTION; TUMOR DIAGNOSIS;

ADENOMATOUS POLYPOSIS COLI; ADOLESCENT; ADULT; CANADA; COLONOSCOPY; COST CONTROL; COST-BENEFIT ANALYSIS; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; MIDDLE AGED; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 0036117928     PISSN: 02664623     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Detection and treatment: Advisory Group on Colorectal Cancer
2. American Gastroenterology Association issues guidelines for colorectal cancer screening
3. Cost comparison of predictive genetic testing versus conventional clinical screening for familial adenomatous polyposis
4. Recommendations for clinical management of familial adenomatous polyposis
5. Survival of patients with hereditary colorectal cancer: Comparison of HNPCC and colorectal cancer in FAP patients with sporadic colorectal cancer
6. Familial adenomatous polyposis (FAP): Frequency, penetrance, and mutation rate
7. Localization of the gene of familial adenomatous polyposis on chromosome 5
8. The establishment of a polyposis register
9. Screening of patients with a positive family history of colorectal cancer
10. Risk and surveillance of individuals with heritable factors for colorectal cancer. WHO Collaborating Centre for the Prevention of Colorectal Cancer
11. Familial colorectal cancer, diagnosis and management
12. Family studies, histopathology, differential diagnosis, and results of treatment
13. American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer: Update 1997
14. Recommendations for the molecular diagnosis of familial adenomatous polyposis
15. Familial adenomatous polyposis
16. Periodic health examination, 1994 update 2: Screening strategies for colorectal cancer
17. Attitudes toward colon cancer gene testing: Factors predicting test uptake
18. Molecular analysis of APC mutations in familial adenomatous polyposis and sporadic colon carcinomas
19. Public health perspectives on testing for colorectal cancer susceptibility genes
20. Cost analysis of alternative approaches to colorectal screening in familial adenomatous polyposis
21. The case for surveillance of high-risk families
22. Colorectal cancer screening: An overview of available methods and current recommendations
23. Ethics and oncogenetics: How to resolve the contradictions?
24. Flexible sigmoidoscopy or colonoscopy for colorectal screening: A randomized trial of performance and acceptability
25. Screening for cancer in high-risk families
26. Cancers of the digestive system
27. Genetic testing in hereditary colorectal cancer (clinical conference)
28. The use and interpretation of commercial APC gene testing for familial adenomatous polyposis
29. Phenotype and cancer risk of various polyposis syndromes
30. Identification and characterization of the familial adenomatous polyposis coli gene
31. Complications and hazards of gastrointestinal endoscopy
32. Phenotypic differences in familial adenomatous polyposis based on APC gene mutation status
33. Gardner syndrome in a man with an interstitial deletion of 5q
34. Endoscopic screening of relatives of patients with colorectal cancer
35. Screening for colorectal cancer
36. Care of patients and their families with familial adenomatous polyposis
37. Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers
38. Genetic testing for cancer risk, how to reconcile the conflicts
39. Discounting in the economic evaluation of health care interventions
40. The gene for familial polyposis coli maps to the long arm of chromosome 5
41. Time preference
42. Colonoscopy in asymptomatic individuals with a family history of colorectal cancer
43. Cancer genetics in the new era of molecular biology
44. Somatic mutations of the APC gene in colorectal tumors, mutation cluster region in the APC gene
45. Mutations of chromosome 5q21 genes in FAP and colorectal cancer
46. Screening for upper gastrointestinal neoplasms in patients with familial adenomatous polyposis and Gardner's syndrome
47. Strategy of screening for patients at high risk of colorectal neoplasm
48. Gene tests and counselling for colorectal cancer risk: Lessons from familial polyposis
49. Screening guidelines and premorbid diagnosis of familial adenomatous polyposis using linkage
50. Molecular diagnosis of familial adenomatous polyposis
51. Colorectal cancer: Risk factors and recommendations for early detection
52. Overview of screening and management of familial adenomatous polyposis
53. Genetics of hereditary colon cancer: A model for prevention
54. Leeds Castle Polyposis Group Meeting
55. Rapid detection of translation-terminating mutations at the adenomatous polyposis coli (APC) gene by direct protein truncation test
56. When should endoscopic screening in familial adenomatous polyposis be started?
57. Molecular genetic tests as a guide to surgical management of familial adenomatous polyposis
58. Correlates of psychologic distress in colorectal cancer patients undergoing genetic testing for hereditary colon cancer
59. Psychological and social consequences of community carrier screening program for cystic fibrosis
60. Recommendations of the Panel of Cost-effectiveness in Health and Medicine
61. Colorectal cancer screening: Clinical guidelines and rationale
62. Risk of colorectal cancer in the families of patients with adenomatous polyps